Clinical Trial Update: Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions [Phase 4]

View source ↗

Summary

Phase 4 trial comparing drug-eluting stents to bare-metal stents for saphenous vein graft interventions in coronary artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Bare-metal stent (bare-metal stent)
• Drug-eluting stent (drug-eluting stent)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED